To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require the displaying of claim denial rates.
Summary
HR9396, introduced by Rep. Goldman (R-TX), would require health insurers to publicly display claim denial rates. The bill is in early legislative stages with referral to three committees. For retail investors, no material near-term impact on health insurer stocks ($UNH) is expected, as compliance costs are negligible relative to revenue.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9396 is an early-stage bill with low probability of near-term passage.
- 2.The requirement to disclose claim denial rates imposes modest compliance costs on health insurers.
- 3.No direct financial impact on $UNH or other insurers at this stage; investors should monitor committee activity.
Market Implications
No immediate implications for healthcare stocks. If the bill advances, it could slightly increase operational costs for insurers like UnitedHealth Group, Elevance Health ($ELV), Humana ($HUM), and Cigna ($CI), but the effect would be negligible compared to revenue. The transparency could lead to regulatory or reputational pressure, but not near-term.
Full Analysis
HR9396 was introduced on June 23, 2026 and referred to the House Committees on Energy and Commerce, Ways and Means, and Education and Workforce. The bill amends the Public Health Service Act, ERISA, and the Internal Revenue Code to mandate that health insurance issuers and group health plans display their claim denial rates. This is a transparency measure that does not alter coverage requirements or pricing. At this early stage — introduced and referred — the likelihood of passage is low. Even if enacted, the compliance burden on large insurers like UnitedHealth Group (UnitedHealthcare) is minimal; tracking and publishing denial rates is an incremental administrative task. No funding is authorized or appropriated. The bill's sponsor is a junior member (Rep. Goldman, R-TX), which further reduces near-term momentum. Structural winners: none. Losers: insurers with high denial rates could face reputational scrutiny, but this is speculative. Timeline: committee consideration likely in 2026-2027 if it advances.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Protecting Health Care and Lowering Costs Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →